Literature DB >> 35142408

Molecular evidences on anti-inflammatory, anticancer, and memory-boosting effects of frankincense.

Mina Khajehdehi1, Mohammad Khalaj-Kondori1, Behzad Baradaran2.   

Abstract

Chemical diversity of natural products with drug-like features has attracted much attention from medicine to develop more safe and effective drugs. Their anti-inflammatory, antitumor, analgesic, and other therapeutic properties are sometimes more successful than chemical drugs in controlling disease due to fewer drug resistance and side effects and being more tolerable in a long time. Frankincense, the oleo gum resin extracted from the Boswellia species, contains some of these chemicals. The anti-inflammatory effect of its main ingredient, boswellic acid, has been traditionally used to treat many diseases, mainly those target memory functions. In this review, we have accumulated research evidence from the beneficial effect of Frankincense consumption in memory improvement and the prevention of inflammation and cancer. Besides, we have discussed the molecular pathways mediating the therapeutic effects of this natural supplement.
© 2022 John Wiley & Sons Ltd.

Entities:  

Keywords:  boswellic acid; cancer; frankincense; inflammation; memory improvement; nutraceutical

Mesh:

Substances:

Year:  2022        PMID: 35142408     DOI: 10.1002/ptr.7399

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  4 in total

Review 1.  How Should the Worldwide Knowledge of Traditional Cancer Healing Be Integrated with Herbs and Mushrooms into Modern Molecular Pharmacology?

Authors:  Yulia Kirdeeva; Olga Fedorova; Alexandra Daks; Nikolai Barlev; Oleg Shuvalov
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-14

Review 2.  Natural and Engineered Nanomaterials for the Identification of Heavy Metal Ions-A Review.

Authors:  Joseph Merillyn Vonnie; Bong Jing Ting; Kobun Rovina; Nasir Md Nur' Aqilah; Koh Wee Yin; Nurul Huda
Journal:  Nanomaterials (Basel)       Date:  2022-08-03       Impact factor: 5.719

3.  Plasma lncRNA profiling identified BC200 and NEAT1 lncRNAs as potential blood-based biomarkers for late-onset Alzheimer's disease.

Authors:  Majid Khodayi; Mohammad Khalaj-Kondori; Mohammad Ali Hoseinpour Feizi; Mortaza Jabarpour Bonyadi; Mahnaz Talebi
Journal:  EXCLI J       Date:  2022-05-09       Impact factor: 4.022

Review 4.  Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild-moderate COVID-19 and prevention of post-COVID cognitive impairment.

Authors:  Adel A Gomaa; Yasmin A Abdel-Wadood; Mohamed A Gomaa
Journal:  Inflammopharmacology       Date:  2022-09-22       Impact factor: 5.093

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.